1. Market Research
  2. > Nutra Pharma Corporation - Product Pipeline Review - 2013

Nutra Pharma Corporation - Product Pipeline Review - 2013

  • July 2013
  • -
  • Global Markets Direct
  • -
  • 28 pages

Nutra Pharma Corporation - Product Pipeline Review - 2013

Summary

Global Markets Direct’s pharmaceuticals report, “Nutra Pharma Corporation - Product Pipeline Review - 2013” provides data on the Nutra Pharma Corporation’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Nutra Pharma Corporation’s corporate website, SEC filings, investor presentations and featured press releases, both from Nutra Pharma Corporation and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Nutra Pharma Corporation - Brief Nutra Pharma Corporation overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Nutra Pharma Corporation human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Nutra Pharma Corporation with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Nutra Pharma Corporation’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Nutra Pharma Corporation’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Nutra Pharma Corporation in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Nutra Pharma Corporation’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Nutra Pharma Corporation.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Nutra Pharma Corporation and identify potential opportunities in those areas.

Table Of Contents

Nutra Pharma Corporation - Product Pipeline Review - 2013
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Nutra Pharma Corporation Snapshot 4
Nutra Pharma Corporation Overview 4
Key Information 4
Key Facts 4
Nutra Pharma Corporation - Research and Development Overview 5
Key Therapeutic Areas 5
Nutra Pharma Corporation - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Nutra Pharma Corporation - Pipeline Products Glance 9
Nutra Pharma Corporation - Late Stage Pipeline 9
Phase III Products/Combination Treatment Modalities 9
Nutra Pharma Corporation Clinical Stage Pipeline Products 10
Phase II Products/Combination Treatment Modalities 10
Phase I Products/Combination Treatment Modalities 11
Nutra Pharma Corporation - Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
Nutra Pharma Corporation - Drug Profiles 13
RPI-70 13
Product Description 13
Mechanism of Action 13
RandD Progress 13
RPI-78 14
Product Description 14
Mechanism of Action 14
RandD Progress 14
RPI-78M 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
RPI-MN 16
Product Description 16
Mechanism of Action 16
RandD Progress 16
Nutra Pharma Corporation - Pipeline Analysis 17
Nutra Pharma Corporation - Pipeline Products by Therapeutic Class 17
Nutra Pharma Corporation - Pipeline Products By Target 19
Nutra Pharma Corporation - Pipeline Products by Route of Administration 20
Nutra Pharma Corporation - Pipeline Products By Mechanism of Action 21
Nutra Pharma Corporation - Recent Pipeline Updates 22
Nutra Pharma Corporation - Company Statement 23
Nutra Pharma Corporation - Locations And Subsidiaries 26
Head Office 26
Other Locations and Subsidiaries 26
Appendix 27
Methodology 27
Coverage 27
Secondary Research 27
Primary Research 27
Expert Panel Validation 27
Contact Us 28
Disclaimer 28

List of Tables

Nutra Pharma Corporation, Key Information 4
Nutra Pharma Corporation, Key Facts 4
Nutra Pharma Corporation - Pipeline by Indication, 2013 6
Nutra Pharma Corporation - Pipeline by Stage of Development, 2013 7
Nutra Pharma Corporation - Monotherapy Products in Pipeline, 2013 8
Nutra Pharma Corporation - Phase III, 2013 9
Nutra Pharma Corporation - Phase II, 2013 10
Nutra Pharma Corporation - Phase I, 2013 11
Nutra Pharma Corporation - Preclinical, 2013 12
Nutra Pharma Corporation - Pipeline By Therapeutic Class, 2013 18
Nutra Pharma Corporation - Pipeline By Target, 2013 19
Nutra Pharma Corporation - Pipeline By Route of Administration, 2013 20
Nutra Pharma Corporation - Pipeline Products By Mechanism of Action, 2013 21
Nutra Pharma Corporation - Recent Pipeline Updates, 2013 22
Nutra Pharma Corporation, Subsidiaries 26

List of Figures

Nutra Pharma Corporation - Pipeline by Indication, 2013 6
Nutra Pharma Corporation - Pipeline by Stage of Development, 2013 7
Nutra Pharma Corporation - Monotherapy Products in Pipeline, 2013 8
Nutra Pharma Corporation - Pipeline By Therapeutic Class, 2013 17
Nutra Pharma Corporation - Pipeline By Route of Administration, 2013 20
Nutra Pharma Corporation - Pipeline Products By Mechanism of Action, 2013 21

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.